PharmItBe
R&D of Drug Products
Company Overview
Snapshot
Founded in December 2015 by Evgenia Lozinsky, PharmItBe operates with 1–10 employees. The company was acquired by TopGum Industries in April 2023, marking a significant exit in the Health Tech & Life Sciences sector.
Business overview
PharmItBe is a pharmaceutical research and development company specializing in the creation of innovative and generic drug products, with a primary focus on topical applications. Operating within the Health Tech & Life Sciences sector, the company develops its core technology to serve the pharmaceutical industry.
Strategic signal
In April 2023, PharmItBe was acquired by TopGum Industries. This acquisition signals a strategic consolidation within the Health Tech & Life Sciences sector, indicating TopGum's expansion into pharmaceutical R&D capabilities and potentially broadening its product portfolio. For investors, this highlights the value of specialized R&D firms in driving innovation and strategic growth for larger industry players.
Log in to access full profile ›Company Intelligence Q&A
- What is PharmItBe's primary focus?
- PharmItBe is primarily focused on the research and development of innovative and generic drug products, with a particular emphasis on topical formulations.
- When was PharmItBe founded?
- PharmItBe was founded in December 2015.
- Who founded PharmItBe?
- PharmItBe was founded by Evgenia Lozinsky, who also served as VP R&D of TopGum.
- What was a significant corporate milestone for PharmItBe?
- Lozinsky as Head of R&D at TopGum.
- In which sector does PharmItBe operate?
- PharmItBe operates in the Health Tech & Life Sciences sector.